BIT biotron limited

0.00%

0.2¢

Ann: Letter to Shareholders, page-102

First 102 Last

Share
Profile

Follow
Tanybryn

288 Posts.

100

23/02/25

22:14

Post #: 77987351
Share

Originally posted by a2zz: ↑

Either on drug or ganja or booze! At one point in time, they mention huge prospects ...., and then immediatelyafter than they yell GIVE money or else get the company out.

If they have guts, let them find investors who will buy each share at $0.11/s, and many I'll sell at $0.11/s price.

After 20+ years, they're threaening to take the company off if they're not able to riase $500K. How many times will they come witht this threat? This time $500K. next time $600K, .... when will they end. They should go into a sea with 500 Kg sand bag ....around their waist to swim against the tide....

We need an Melon who would ask each individual like MM or Hoy in a company like Biotron and others in Govt to report about the work they have done in a week. R&D benefits taken for years were not propery used. If the work is meanignful, they will get paid, if not meaningful, they will get unpaid.

MM, HOY PN should have been unpaid until a tangible deal is done. If there was a fair govt system in place, people like MM and Hoy and PN would be caught red handed and fined from the super they have accumulated from the SHs and Tax payers money. Govt system need to be reformed. Too much bereaurocracy to tackle companies like Biotron!

Let MM get a tangible deal, and SHs will pay money required to complete the negotiations. Currently none trust MM, Hoy, PN!
MM, Hoy, PN are taking the advantage of the bereaurocracy that has utterly replaced the democracy.

Expand

So here are the details of Lipotek Pty Ltd
Another biotech company brewing in the John Curtin School of Medical Research at The Australian National University, just waiting to be listed and also chaired by our Chairman Hoy

I have emailed them to beware the Chairman of doom who has presided over the trashing of this ANU spinoff and allowed the CEO to bumble on spinning her yarn to the destruction of Shareholders capital for 20 years

Try and put a holt to this gravy train if you can
Dr Ines Atmosukarto
Chief Executive
Ines at lipotek dot com dot au

BIT Price at posting: 0.8¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

First 102 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.2¢		Change 0.000(0.00%)		Mkt cap ! $2.654M

Open	High	Low	Value	Volume
0.2¢	0.2¢	0.2¢	$210	104.8K

Buyers (Bids)

No.	Vol.	Price($)
64	38848316	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	18281126	25

View Market Depth

No.	Vol.	Price($)
59	37148316	0.002
33	65631001	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	14162401	23
0.004	12820969	17
0.005	6684000	5
0.006	1200000	2
0.007	1084188	2

Last trade - 12.28pm 27/06/2025 (20 minute delay)

BIT (ASX) Chart

Ann: Letter to Shareholders, page-102

Dr Ines Atmosukarto
Chief Executive

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Letter to Shareholders, page-102

Dr Ines AtmosukartoChief Executive

Top Stories

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Dr Ines Atmosukarto
Chief Executive